Genertec Universal Medical Group Company Limited (F:5UM) — Market Cap & Net Worth
Market Cap & Net Worth: Genertec Universal Medical Group Company Limited (5UM)
Genertec Universal Medical Group Company Limited (F:5UM) has a market capitalization of $1.00 Billion (€857.98 Million) as of September 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #8900 globally and #1146 in its home market, demonstrating a -2.85% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genertec Universal Medical Group Company Limited's stock price €0.48 by its total outstanding shares 2014204924 (2.01 Billion). Also see total assets of Genertec Universal Medical Group Company for a full breakdown of the balance sheet.
Genertec Universal Medical Group Company Limited Market Cap History: 2015 to 2026
Genertec Universal Medical Group Company Limited's market capitalization history from 2015 to 2026. Data shows growth from $103.61 Million to $1.13 Billion (24.60% CAGR). Also see Genertec Universal Medical Group Company operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Genertec Universal Medical Group Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genertec Universal Medical Group Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Genertec Universal Medical Group Company for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.10x
Genertec Universal Medical Group Company Limited's market cap is 0.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.67x
Genertec Universal Medical Group Company Limited's market cap is 0.67 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $145.53 Million | $2.70 Billion | $872.31 Million | 0.05x | 0.17x |
| 2017 | $192.15 Million | $3.42 Billion | $1.15 Billion | 0.06x | 0.17x |
| 2018 | $231.01 Million | $4.30 Billion | $1.35 Billion | 0.05x | 0.17x |
| 2019 | $402.67 Million | $6.82 Billion | $1.59 Billion | 0.06x | 0.25x |
| 2020 | $826.31 Million | $8.52 Billion | $1.75 Billion | 0.10x | 0.47x |
| 2021 | $1.41 Billion | $9.91 Billion | $1.95 Billion | 0.14x | 0.73x |
| 2022 | $1.30 Billion | $11.91 Billion | $1.96 Billion | 0.11x | 0.66x |
| 2023 | $1.18 Billion | $13.65 Billion | $2.11 Billion | 0.09x | 0.56x |
| 2024 | $1.35 Billion | $13.66 Billion | $2.10 Billion | 0.10x | 0.64x |
| 2025 | $1.47 Billion | $14.94 Billion | $2.21 Billion | 0.10x | 0.67x |
Competitor Companies of 5UM by Market Capitalization
Companies near Genertec Universal Medical Group Company Limited in the global market cap rankings as of September 19, 2026. Review Genertec Universal Medical Group Company (5UM) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Genertec Universal Medical Group Company Limited by market ranking:
- Visa Inc. Class A (NYSE:V): Ranked #27 globally with a market cap of $630.40 Billion USD.
- Mastercard Inc (NYSE:MA): Ranked #36 globally with a market cap of $429.87 Billion USD.
- American Express Company (NYSE:AXP): Ranked #97 globally with a market cap of $212.32 Billion USD.
- Capital One Financial Corporation (NYSE:COF): Ranked #200 globally with a market cap of $123.95 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #27 | Visa Inc. Class A | NYSE:V | $630.40 Billion | $369.93 |
| #36 | Mastercard Inc | NYSE:MA | $429.87 Billion | $565.73 |
| #97 | American Express Company | NYSE:AXP | $212.32 Billion | $311.17 |
| #200 | Capital One Financial Corporation | NYSE:COF | $123.95 Billion | $202.04 |
Genertec Universal Medical Group Company Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Genertec Universal Medical Group Company Limited's market cap moved from $103.61 Million to $ 1.13 Billion, with a yearly change of 24.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.13 Billion | -23.52% |
| 2025 | €1.47 Billion | +8.70% |
| 2024 | €1.35 Billion | +15.00% |
| 2023 | €1.18 Billion | -9.09% |
| 2022 | €1.30 Billion | -8.33% |
| 2021 | €1.41 Billion | +70.99% |
| 2020 | €826.31 Million | +105.20% |
| 2019 | €402.67 Million | +74.31% |
| 2018 | €231.01 Million | +20.22% |
| 2017 | €192.15 Million | +32.04% |
| 2016 | €145.53 Million | +40.45% |
| 2015 | €103.61 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Genertec Universal Medical Group Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.00 Billion USD |
| MoneyControl | $1.00 Billion USD |
| MarketWatch | $1.00 Billion USD |
| marketcap.company | $1.00 Billion USD |
| Reuters | $1.00 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Genertec Universal Medical Group Company Limited
Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the Mainland China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. Its Healthcare Business segment inc… Read more